Nuzenio

Core Biomedicine

Core Biomedicine news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 4 publisher sources 100/100 entity strength

Latest news

CORE Biomedicine Deepens Precision Oncology Pipeline With $21 Million Funding Round and Eisai Licensing Deal - TipRanksTipRanks · Sat, 01 Aug 2026 16:03:02 GMT Eisai and CORE Biomedicine agree on global licence for oncology pipeline - Pharmaceutical TechnologyPharmaceutical Technology · Wed, 29 Jul 2026 07:54:40 GMT 12 Funding Rounds That Show Where APAC Biotech Capital Is Going - BioPharma APACBioPharma APAC · Wed, 29 Jul 2026 06:57:42 GMT CORE Biomedicine Secures Global Rights to Eisai Oncology Portfolio to Advance Precision Cancer Therapies - TipRanksTipRanks · Tue, 28 Jul 2026 13:34:39 GMT CORE Biomedicine Raises $21 Million Series A and Secures AMED Grant to Advance Lineage-Based Cancer Drugs - TipRanksTipRanks · Tue, 28 Jul 2026 13:34:39 GMT CORE Biomedicine Signs Exclusive Licensing Agreement with Eisai for Precision Oncology Programs - PR NewswirePR Newswire · Tue, 28 Jul 2026 12:21:00 GMT CORE Biomedicine Secures $21 Million Series A Venture Financing and Receives AMED Grant Award to Advance Novel Cancer Therapeutics - PR NewswirePR Newswire · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Sat, 01 Aug 2026 16:03:02 GMTCORE Biomedicine Deepens Precision Oncology Pipeline With $21 Million Funding Round and Eisai Licensing Deal - TipRanks

Wed, 29 Jul 2026 07:54:40 GMTEisai and CORE Biomedicine agree on global licence for oncology pipeline - Pharmaceutical Technology

Wed, 29 Jul 2026 06:57:42 GMT12 Funding Rounds That Show Where APAC Biotech Capital Is Going - BioPharma APAC

Tue, 28 Jul 2026 13:34:39 GMTCORE Biomedicine Secures Global Rights to Eisai Oncology Portfolio to Advance Precision Cancer Therapies - TipRanks

Tue, 28 Jul 2026 13:34:39 GMTCORE Biomedicine Raises $21 Million Series A and Secures AMED Grant to Advance Lineage-Based Cancer Drugs - TipRanks

Tue, 28 Jul 2026 12:21:00 GMTCORE Biomedicine Signs Exclusive Licensing Agreement with Eisai for Precision Oncology Programs - PR Newswire

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Million Series A4 live mentions TipRanks CORE Biomedicine3 live mentions Eisai3 live mentions Million Funding Round2 live mentions Eisai Licensing Deal2 live mentions TipRanks TipRanks2 live mentions Funding Rounds That2 live mentions Show Where APAC2 live mentions Biotech Capital Is2 live mentions BioPharma APAC2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Core Biomedicine.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.